Insider Transactions

What Chemomab Therapeutics Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	2
Sells	2	2
Total trades	2	6

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 6 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Cohen Neil Harris	Director	Aug 28	Open-market sale · S	−1,000	$2.80	−$2.8K	33,000
Cohen Neil Harris	Director	Aug 27	Open-market sale · S	−1,304	$2.85	−$3.72K	34,000
Mor George Adi	Chief Executive Officer	May 29	Other Transaction · J	−18,750	—	—	18,750
Mor George Adi	Chief Executive Officer	May 29	Other Transaction · J	−31,712	—	—	31,712
Mor George Adi	Chief Executive Officer	May 29	Open-market buy · P	−4,926	$2.08	−$10.2K	139,131
Mor George Adi	Chief Executive Officer	May 29	Open-market buy · P	−4,878	$2.05	−$10K	134,205
OrbiMed Israel Gp Ltd.	10% owner	Jan 03	Open-market sale · S	−70,524	$4.51	−$318K	2,241,274
OrbiMed Israel Gp Ltd.	10% owner	Jan 03	Open-market sale · S	−266,376	$3.34	−$890K	2,311,798
Mor George Adi	Chief Scientific Officer	Jan 03	Open-market sale · S	−6,100	$5.03	−$30.7K	251,147
Mor George Adi	Chief Scientific Officer	Jan 03	Open-market sale · S	−7,700	$5.03	−$38.7K	317,075
Mor George Adi	Chief Scientific Officer	Nov 16	Open-market sale · S	−257,248	$2.08	−$536K	257,247
Mor George Adi	Chief Scientific Officer	Nov 16	Open-market sale · S	−324,775	$2.08	−$677K	324,775
Cohen Neil Harris	Director	Nov 16	Open-market sale · S	−2,409	$2.00	−$4.82K	10,000
Maryles Joel Michael	Director	May 24	Open-market buy · P	+33	$2.76	+$91.1	1,433
Maryles Joel Michael	Director	May 24	Open-market buy · P	+400	$2.89	+$1.16K	1,400
Cohen Neil Harris	Director	May 18	Open-market buy · P	+2,000	$3.19	+$6.38K	12,409
Maryles Joel Michael	Director	Mar 18	Open-market buy · P	+500	$4.36	+$2.18K	1,000
Maryles Joel Michael	Director	Mar 18	Open-market buy · P	+500	$4.32	+$2.16K	500
Marvin Donald	Executive VP, CFO & COO	Mar 16	Open-market buy · P	+250	$3.25	+$813	2,000
Marvin Donald	Executive VP, CFO & COO	Mar 16	Open-market buy · P	+250	$3.30	+$825	1,750

Page 1 of 2 · showing the 20 most recent Sign up free to view all 35 transactions and filter by insider →